fulvestrant has been researched along with Angiogenesis, Pathologic in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Abrahamsson, A; Dabrosin, C; Rodriguez, GV | 1 |
| Cheng, J; Hong, Q; Jia, X; Lei, L; Li, D; Li, J; Liu, G; Mo, M; Shao, Z; Shen, Z; Wang, Y | 1 |
| Albrecht, M; Brown, JA; Brown, MB; Dieudonne, D; Fisher, AJ; Justice, MJ; Lahm, T; Patel, NG; Petrache, I; Presson, RG; Reddy, JG; Selej, M; Trulock, KM; Van Demark, M | 1 |
| Geliebter, J; George, AL; Kamat, A; Rajoria, S; Schantz, SP; Suriano, R; Tiwari, RK | 1 |
| Hyder, SM; Liang, Y; Uray, IP | 1 |
| Gärtner, F; Guo, S; Russo, J; Schmitt, FC; Soares, R | 1 |
| Gartenhaus, RB; Jarrett, J; Jordan, VC; Levenson, AS; Osipo, C; Satcher, RL; Simons, LA; Thurn, KE; Veliceasa, D; Volpert, OV | 1 |
| Bhartiya, D; Cid, MC; Grant, DS; Kleinman, HK; Maheshwari, S; McGowan, KA; Morales, DE; Schnaper, HW | 1 |
| Collins, DC; Gagliardi, A | 1 |
9 other study(ies) available for fulvestrant and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Fulvestrant-Mediated Attenuation of the Innate Immune Response Decreases ER
Topics: Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Estrogen Receptor Antagonists; Female; Fulvestrant; Humans; Immunity, Innate; MCF-7 Cells; Mice, Nude; Microdialysis; Neovascularization, Pathologic; Receptors, Estrogen; Tamoxifen; Tumor Microenvironment; Xenograft Model Antitumor Assays; Zebrafish | 2020 |
Basal and therapy-driven hypoxia-inducible factor-1α confers resistance to endocrine therapy in estrogen receptor-positive breast cancer.
Topics: Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Hypoxia; Cell Line, Tumor; Diphosphonates; Drug Resistance, Neoplasm; Estradiol; Estrogens; Female; Fulvestrant; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Imidazoles; Letrozole; MAP Kinase Signaling System; Mice; Mice, Nude; Neoadjuvant Therapy; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Neovascularization, Pathologic; Nitriles; Postmenopause; Receptors, Estrogen; RNA Interference; RNA, Small Interfering; Transcription, Genetic; Treatment Outcome; Triazoles; Xenograft Model Antitumor Assays; Zoledronic Acid | 2015 |
17β-Estradiol attenuates hypoxic pulmonary hypertension via estrogen receptor-mediated effects.
Topics: Airway Remodeling; Animals; Blood Pressure; Cardiac Output; Cyclin-Dependent Kinase Inhibitor p27; Estradiol; Estrogen Antagonists; Fulvestrant; Hypertension, Pulmonary; Hypoxia; Lung; Male; Neovascularization, Pathologic; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Ventricular Remodeling | 2012 |
Molecular target based combinational therapeutic approaches in thyroid cancer.
Topics: Antibodies, Neutralizing; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Movement; Cell Proliferation; Culture Media, Conditioned; Down-Regulation; Estradiol; Estrogens; Female; Fulvestrant; Human Umbilical Vein Endothelial Cells; Humans; Indoles; Male; Molecular Targeted Therapy; Neovascularization, Pathologic; Thyroid Neoplasms; Vascular Endothelial Growth Factor A | 2012 |
Estradiol down-regulates CD36 expression in human breast cancer cells.
Topics: Antineoplastic Agents, Hormonal; Apoptosis; Blotting, Northern; Breast Neoplasms; CD36 Antigens; Cell Division; Cell Line, Tumor; Dose-Response Relationship, Drug; Down-Regulation; Estradiol; Female; Fulvestrant; Humans; Neovascularization, Pathologic; Receptors, Progesterone; Reverse Transcriptase Polymerase Chain Reaction; RNA; Thrombospondin 1; Time Factors | 2004 |
17 beta -estradiol-mediated vessel assembly and stabilization in tumor angiogenesis requires TGF beta and EGFR crosstalk.
Topics: Adrenal Medulla; Animals; Aorta; Blotting, Western; Breast Neoplasms; Cattle; Cell Line; Cell Line, Tumor; Coculture Techniques; Collagen; Culture Media, Conditioned; Culture Media, Serum-Free; Drug Combinations; Endothelium, Vascular; ErbB Receptors; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Gene Expression Regulation; Humans; Laminin; Muscle, Smooth; Neovascularization, Pathologic; Proteoglycans; Receptor Cross-Talk; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Transforming Growth Factor beta; Umbilical Veins | 2003 |
MCT-1 oncogene contributes to increased in vivo tumorigenicity of MCF7 cells by promotion of angiogenesis and inhibition of apoptosis.
Topics: Animals; Apoptosis; Breast Neoplasms; Cell Cycle Proteins; Cell Line, Tumor; Estradiol; Estrogen Receptor alpha; Female; Fulvestrant; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Oncogene Proteins; Transfection | 2005 |
Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in a murine model.
Topics: Animals; Cell Adhesion; Cell Division; Cell Movement; Cells, Cultured; Collagen; Drug Combinations; Endothelium, Vascular; Estradiol; Female; Fibroblast Growth Factor 2; Fulvestrant; Humans; Laminin; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Proteoglycans; Umbilical Veins | 1995 |
Inhibition of angiogenesis by antiestrogens.
Topics: Animals; Chick Embryo; Clomiphene; Dimethyl Sulfoxide; Dimethylformamide; Dose-Response Relationship, Drug; Drug Interactions; Estradiol; Estrogen Antagonists; Fulvestrant; Heparin; Hydrocortisone; Nafoxidine; Neovascularization, Pathologic; Polyunsaturated Alkamides; Solubility; Tamoxifen | 1993 |